OPGN

OpGen, Inc. OPGN

OPGN
OpGen, Inc. HSCS
HeartSciences Inc. NAOV
NanoVibronix, Inc. RPID
Rapid Micro Biosystems, Inc. THMO
ThermoGenesis Holdings, Inc. BMRA
Biomerica, Inc. AYTU
Aytu BioPharma, Inc. PRPO
Precipio, Inc. TRAW
Traws Pharma, Inc. AIM
AIM ImmunoTech Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode OPGN HSCS NAOV RPID THMO BMRA AYTU PRPO TRAW AIM
6M -100.00 % 3.75 % -90.84 % 74.75 % -66.67 % -34.24 % 125.96 % 235.69 % 45.75 % -12.50 %
YTD -99.98 % -4.30 % -90.91 % 259.07 % -85.71 % 16.30 % 38.24 % 254.48 % -66.38 % -88.07 %
1Y -99.99 % -0.02 % -90.91 % 298.42 % -99.95 % 3.47 % 3.98 % 195.49 % -41.82 % -89.90 %
3Y -100.00 % -97.23 % -99.36 % 11.36 % -100.00 % -91.12 % -30.88 % 12.83 % -83.34 % -94.53 %
5Y -100.00 % -97.89 % -99.60 % -83.50 % -100.00 % -95.51 % -98.85 % -57.40 % -97.71 % -98.89 %
10Y -100.00 % -97.89 % -99.93 % -83.50 % -100.00 % -62.97 % -100.00 % -99.30 % -100.00 % -99.97 %
From the beginning -100.00 % -97.89 % -99.92 % -83.50 % -100.00 % -93.30 % -100.00 % -99.30 % -100.00 % -71.37 %

Dividend